AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and management of graft-related complications

While robust clinical trial data provide strong guidance on some aspects of graft management in LT such as machine perfusion and immunosuppression efficacy and safety, a significant component of graft management is derived from retrospective cohort data, extrapolation of data from other solid organ transplants, or expert opinion, including the treatment of antibody-mediated rejection. Finally, further investigation is needed to truly optimize the management of the liver allograft, including the prevention of recurrent alcohol-associated, metabolic dysfunction-associated steatotic and immune-mediated liver diseases.

Authors

Institutions

Publication Details

Journal
Liver Transplantation
Published
2025-08-22
DOI
https://doi.org/10.1097/lvt.0000000000000715
Citations
2
Primary Topic
Organ Transplantation Techniques and Outcomes
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and management of graft-related complications

Helen S. Te, Vatche G. Agopian, Gerald Scott Winder, Brendan M. McGuire et al.
2 citations
Liver Transplantation
Organ Transplantation Techniques and Outcomes
4.01
article

AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and management of graft-related complications

Helen S. Te, Vatche G. Agopian, Gerald Scott Winder, Brendan M. McGuire, W. Kenneth Washburn, Paul Y. Kwo, Nazia Selzner, Mark W. Russo, Thomas Schiano, A J Demetris
article en
2 citations

Abstract

While robust clinical trial data provide strong guidance on some aspects of graft management in LT such as machine perfusion and immunosuppression efficacy and safety, a significant component of graft management is derived from retrospective cohort data, extrapolation of data from other solid organ transplants, or expert opinion, including the treatment of antibody-mediated rejection. Finally, further investigation is needed to truly optimize the management of the liver allograft, including the prevention of recurrent alcohol-associated, metabolic dysfunction-associated steatotic and immune-mediated liver diseases.

Liver TransplantationVol. 32(3)
Mount Sinai Hospital (US), University Health Network (CA), California NanoSystems Institute (US), Henry Ford Health System (US), University of California, Los Angeles (US), University of Michigan (US), Carolinas Medical Center (US), The Ohio State University Wexner Medical Center (US), University of Alabama at Birmingham (US), University of Illinois Chicago (US), University of Chicago (US), University of Chicago Medical Center (US), Mount Sinai Medical Center (US), Royal Pavilion (GB), Michigan Medicine (US), Ann Arbor VA Medical Center (US), UPMC Montefiore (US), Stanford University (US)
Openalex Percentile: Top 6%
Organ Transplantation Techniques and Outcomes
4.01
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.